UBS Securities

In a report published Thursday, UBS Securities analyst Steven Fisher reiterated a Neutral rating on Layne Christensen Company (NASDAQ: LAYN), but lowered the price target from $12.00 to $8.75. In the report, UBS Securities noted, “LAYN is beginning to make material changes to both its business and...

In a report published Thursday, UBS Securities analyst Andrew Peters reiterated a Buy rating on BioMarin Pharmaceutical (NASDAQ: BMRN), and raised the price target from $87.00 to $112.00. In the report, UBS Securities noted, “We see BioMarin as a top pick in biotech heading into 2015, with a well-...

Following the company's fourth quarter 2014 earnings report, a number of firms have issued notes detailing their revised view on Microsoft's (NASDAQ: MSFT) stock. Bank of America: Upgraded From Underperform To Neutral, Raised Price Objective From $35 To $47. "In our view, the Street...

In a report published Tuesday, UBS Securities analyst Stephen Chin reiterated a Neutral rating on Texas Instruments (NASDAQ: TXN), and raised the price target from $49.00 to $52.00. In the report, UBS Securities noted, “A number of things went right with TI's Q2 results as broad-based growth led by...

In a report published Tuesday, UBS Securities analyst Matt Murphy reiterated a Buy rating on Steel Dynamics (NASDAQ: STLD), and raised the price target from $21.00 to $23.00. In the report, UBS Securities noted, “STLD expects Columbus to generate some $270M in EBITDA in 2015E or ~$90/t, as implied...

In a report published Tuesday, UBS Securities analyst Angie Sedita reiterated a Buy rating on Halliburton (NYSE: HAL), and raised the price target from $80.00 to $87.00. In the report, UBS Securities noted, “We are raising our 2015 EPS ests by 7.5% and 2% in 2014E. Our forecasts reflect slightly...

In a report published Tuesday, UBS Securities analyst Keith Siegner reiterated a Neutral rating on Chipotle Mexican Grill (NYSE: CMG), and raised the price target from $530.00 to $600.00. In the report, UBS Securities noted, “CMG delivered one of the best beats in recent memory, blowing away...

In a report published Tuesday, UBS Securities analyst Marc Goodman upgraded the rating on Allergan (NYSE: AGN) from Neutral to Buy, and raised the price target from $180.00 to $200.00. In the report, UBS Securities noted, “Investors have been waiting for 2 Allergan events: a restructuring and an...

In a report published Tuesday, UBS Securities analyst Julien Dumoulin-Smith initiated coverage on NextEra Energy Partners LP (NYSE: NEP) with a Neutral rating and $34.00 price target. In the report, UBS Securities noted, “NextEra Energy Partners (NEP) has sprinted upwards from the start line, with...

Shares of GT Advanced Technologies (NASDAQ: GTAT) are down 8.85 percent in Monday's pre-market session following a downgrade from Buy to Neutral by UBS analyst Stephen Chin. Chin stated, "We believe GT can still hit the midpoint of its sales guidance of $600-$800M but believe our...

In a report published Tuesday, UBS Securities analyst Jason DeRise reiterated a Neutral rating and $75.00 price target on United Natural Foods (NASDAQ: UNFI). In the report, UBS Securities noted, “In our US Natural Foods Retail Q-Series ‘Are the aisles wide enough for all competitors?' our bottom...

In a report published Tuesday, UBS Securities analyst Jason DeRise reiterated a Buy rating and $45.00 price target on The Fresh Market (NASDAQ: TFM). In the report, UBS Securities noted, “Fresh Market disappointed investors throughout 2013 with just 4% EPS growth despite opening 15% new units. The...

In a report published Tuesday, UBS Securities analyst Jason DeRise upgraded the rating on Sprouts Farmers Market (NASDAQ: SFM) from Neutral to Buy, and raised the price target from $41.00 to $43.00. In the report, UBS Securities noted, “Sprouts has taken a conservative approach to its guidance, by...

In a report published Wednesday, UBS Securities analyst Julien Dumoulin-Smith downgraded the rating on Calpine (NYSE: CPN) from Buy to Neutral, but reiterated the $22.00 price target. In the report, UBS Securities noted, “We're downgrading shares to Neutral from Buy following its latest move, and...

In a report published Wednesday, UBS Securities analyst Steven Valiquette downgraded the rating on Patterson Companies (NASDAQ: PDCO) from Buy to Neutral, but reiterated the $46.00 price target. In the report, UBS Securities noted, “Based on strong U.S. trends from dental/vet peers, and a much...